Goldman Sachs Reaffirms Neutral Rating on Cochlear (COH)
Cochlear remained flat at A$74.770 during trading on Monday. Cochlear has a 52-week low of A$51.310 and a 52-week high of A$71.790. The company has a market cap of A$4.252 billion and a price-to-earnings ratio of 74.92.
Separately, analysts at Nomura reiterated a “neutral” rating on shares of Cochlear in a research note to investors on Tuesday, October 30th. They now have a $70.31 price target on the stock.
Cochlear Limited (Cochlear) is an Australia-based company, which operates in the implantable hearing device industry.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.